Sigyn Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2014
Market Capitalization	6	5	254	728	376	1,941	Upgrade
Market Cap Growth	-97.07%	-97.96%	-65.07%	93.40%	-80.61%	7356.76%	Upgrade
Enterprise Value	9	8	256	729	377	1,943	Upgrade
PE Ratio	-	-1.25	-68.51	-213.87	-234.84	-620.13	Upgrade
PS Ratio	414.18	-	-	-	-	13542.48	Upgrade
PB Ratio	-1.68	-1.52	-133.61	-2751.23	3795.01	-788.78	Upgrade
P/FCF Ratio	-6.41	-3.75	-138.88	-403.63	-447.75	-13508.36	Upgrade
P/OCF Ratio	-6.41	-3.75	-138.94	-410.29	-453.58	-13508.36	Upgrade
EV/Sales Ratio	594.77	-	-	-	-	13555.73	Upgrade
EV/EBITDA Ratio	-3.67	-3.10	-112.72	-355.32	-416.31	-4389.28	Upgrade
EV/EBIT Ratio	-3.66	-3.09	-112.20	-352.03	-411.18	-3750.95	Upgrade
EV/FCF Ratio	-8.88	-5.48	-139.90	-403.96	-448.27	-13521.58	Upgrade
Debt / Equity Ratio	-0.66	-0.70	-0.99	-3.53	5.23	-0.77	Upgrade
Debt / EBITDA Ratio	-1.04	-0.98	-0.83	-0.46	-0.57	-4.29	Upgrade
Debt / FCF Ratio	-2.51	-1.73	-1.03	-0.52	-0.62	-13.22	Upgrade
Quick Ratio	0.01	0.00	0.00	0.46	0.14	0.00	Upgrade
Current Ratio	0.03	0.03	0.03	0.54	1.13	0.19	Upgrade
Asset Turnover	0.05	0	0	0	0	0.22	Upgrade
Interest Coverage	-4.92	-1.20	-3.32	-5.03	-2.67	-9.38	Upgrade
Return on Equity (ROE)	88.60%	121.49%	195.03%	1286.43%	-1616.01%	127.20%	Upgrade
Return on Assets (ROA)	-1102.09%	-1288.33%	-1115.10%	-479.22%	-230.92%	-487.41%	Upgrade
Return on Capital (ROIC)	186.97%	241.96%	8271.76%	-300.03%	-148.33%	92.33%	Upgrade
Earnings Yield	-59.36%	-79.83%	-1.46%	-0.47%	-0.43%	-0.16%	Upgrade
FCF Yield	-17.60%	-26.63%	-0.72%	-0.25%	-0.22%	-0.01%	Upgrade
Buyback Yield / Dilution	96.80%	97.06%	-2.75%	-395.11%	-1256.72%	-24.90%	Upgrade
Total Shareholder Return	96.80%	97.06%	-2.75%	-395.11%	-1256.72%	-24.90%	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.